[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$HIMS Q3 '25: Revenue $599M (beat +49% YoY) subs 2.5M (+21%) EBITDA $78M (+53%). EPS $XXXX miss vs $XXXX net income $16M (down big from one-off). Guidance: FY rev $2.3352.355B Q4 $605625M (soft vs street). Hers $1B+ '26 + Novo in the works Just imagine what happens with peptides in the next XX months 👀"
X Link @BoujeeFinances 2025-11-04T03:31Z 9445 followers, 1335 engagements
"Whoa $HIMS just dropped Q3 🔥 : revenue $599M up XX% YoY 📈 subscribers hit 2.47M (+21%) growth screaming. But heres the kicker Adjusted EBITDA margin is holding at XX% and full-year guidance is $2.335-2.355B revenue & $307-317M EBITDA so growth is strong but margin expansion seems cautious. #stocks #HIMS #telehealth #growthmindset"
X Link @CPolagoni 2025-11-03T22:13Z XXX followers, XXX engagements
"$HIMS Q3 Earnings Report is out. Revenue of $599M vs. $579.9M est. 🟢 Adj. EBITDA of $78.4M vs. $68M est. 🟢 EPS of $XXXX vs. $XXXX est. 🔴 Free Cash Flow of $79.4M flat YoY Q4 Revenue guidance of $605-625M vs. $629.6M est. 🔴 Q4 Adj. EBITDA guidance of $55-65M vs. $75.6M est. 🔴 Lowers FY2025 Revenue guidance to $2.335-2.355B vs. $2.342B est. 🟡 Narrows FY2025 Adj. EBITDA guidance to $307-317M vs. $316.9M est. 🔴"
X Link @mvcinvesting 2025-11-03T21:08Z 78K followers, 78.6K engagements